1、2023Annual ReportKEY FIGURES 2023Merck GroupNet sales millionMerck GroupMerck GroupEBITDA pre1 million1 Not defined by International Financial Reporting Standards(IFRS).Change million20232022 million%Net sales20,99322,232-1,239-5.6%Operating result(EBIT)13,6094,474-865-19.3%Margin(%of net sales)117.
2、2%20.1%EBITDA25,4896,504-1,015-15.6%Margin(%of net sales)126.1%29.3%EBITDA pre 15,8796,849-970-14.2%Margin(%of net sales)128.0%30.8%Profit after tax2,8343,339-505-15.1%Earnings per share(in)6.497.65-1.16-15.2%Earnings per share pre()18.4910.05-1.56-15.5%Operating cash flow 3,7844,259-475-11.2%1 Not
3、defined by International Financial Reporting Standards(IFRS).2 Not defined by International Financial Reporting Standards(IFRS);EBITDA corresponds to operating result(EBIT)adjusted by depreciation,amortization,impairment losses,and reversals of impairment losses.AT A GLaNCEA strong teamLife Science
4、Together,we impact life and health with science.Net sales per regionHealthcare We help to create,im-prove and prolong lives.ElectronicsWe are advancing digital living.employees62,908Share ofnet sales44%Share ofnet sales38%Share ofnet sales18%Share ofEBITDA pre45%Share ofEBITDA pre41%Share ofEBITDA p
5、re15%nationalities141women in leadership positions39%Asia-Pacific 6,936 millionEurope 6,037 millionNorth America 5,952 millionLatin America 1,331 millionMiddle East and Africa 737 millionTo our Shareholders 6 Letter from Beln Garijo 8 The Executive Board 9 Merck Shares Combined Management Report 13
6、Fundamental Information about the Group 13 Merck 22 Strategy 28 Internal Management System 35 Research and Development 48 Report on Economic Position 48 Macroeconomic and Sector-Specific Environment 52 Review of Forecast against Actual Business Development 55 Course of Business and Economic Position